Investors | Eli Lilly and CompanyLilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1 | Eli Lilly and ...Apr 28, 2022more_vert
BloombergObesity Drug Helps Patients Lose About 20% of Weight, Lilly SaysApr 28, 2022Emma CourtBy Emma Courtmore_vert
The New York TimesPatients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims (Published 2022)May 1, 2022Gina KolataBy Gina Kolatamore_vert
Financial TimesEli Lilly says obesity drug has similar results to weight-loss surgeryApr 28, 2022Hannah Kuchler & Jamie SmythBy Hannah Kuchler & Jamie Smythmore_vert